AR013115A1 - COMPUESTOS DE 2,6-DI-t-BUTIL-4-[(DIMETIL-METOXIFENILSILIL)METIL-OXI]FENOL UTILES EN LA INHIBICION DE LA ARTERIOESCLEROSIS, COMPOSICIONES FARMACEUTICASY USOS EN LA FABRICACION DE MEDICAMENTOS QUE INCLUYEN DICHOS COMPUESTOS - Google Patents
COMPUESTOS DE 2,6-DI-t-BUTIL-4-[(DIMETIL-METOXIFENILSILIL)METIL-OXI]FENOL UTILES EN LA INHIBICION DE LA ARTERIOESCLEROSIS, COMPOSICIONES FARMACEUTICASY USOS EN LA FABRICACION DE MEDICAMENTOS QUE INCLUYEN DICHOS COMPUESTOSInfo
- Publication number
- AR013115A1 AR013115A1 ARP980102978A ARP980102978A AR013115A1 AR 013115 A1 AR013115 A1 AR 013115A1 AR P980102978 A ARP980102978 A AR P980102978A AR P980102978 A ARP980102978 A AR P980102978A AR 013115 A1 AR013115 A1 AR 013115A1
- Authority
- AR
- Argentina
- Prior art keywords
- butyl
- inhibition
- methyl
- compounds
- manufacture
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 239000003814 drug Substances 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 title abstract 2
- 230000005764 inhibitory process Effects 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 title 1
- PVQMRIYBVJAQBE-UHFFFAOYSA-N 2,6-ditert-butyl-4-[[(2-methoxyphenyl)-dimethylsilyl]methoxy]phenol Chemical compound COC1=CC=CC=C1[Si](C)(C)COC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 PVQMRIYBVJAQBE-UHFFFAOYSA-N 0.000 abstract 1
- PJKUTMONJXDZNR-UHFFFAOYSA-N 2,6-ditert-butyl-4-[[(4-methoxyphenyl)-dimethylsilyl]methoxy]phenol Chemical compound C1=CC(OC)=CC=C1[Si](C)(C)COC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 PJKUTMONJXDZNR-UHFFFAOYSA-N 0.000 abstract 1
- 206010003210 Arteriosclerosis Diseases 0.000 abstract 1
- 230000002930 anti-sclerotic effect Effects 0.000 abstract 1
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88184397A | 1997-06-25 | 1997-06-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR013115A1 true AR013115A1 (es) | 2000-12-13 |
Family
ID=25379324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980102978A AR013115A1 (es) | 1997-06-25 | 1998-06-22 | COMPUESTOS DE 2,6-DI-t-BUTIL-4-[(DIMETIL-METOXIFENILSILIL)METIL-OXI]FENOL UTILES EN LA INHIBICION DE LA ARTERIOESCLEROSIS, COMPOSICIONES FARMACEUTICASY USOS EN LA FABRICACION DE MEDICAMENTOS QUE INCLUYEN DICHOS COMPUESTOS |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0996623A1 (xx) |
JP (1) | JP2002506443A (xx) |
AR (1) | AR013115A1 (xx) |
AU (1) | AU7588498A (xx) |
CA (1) | CA2295232A1 (xx) |
WO (1) | WO1998058937A1 (xx) |
ZA (1) | ZA985324B (xx) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5155250A (en) * | 1990-07-05 | 1992-10-13 | Merrell Dow Pharmaceuticals Inc. | 2,6-di-alkyl-4-silyl-phenols as antiatheroscerotic agents |
EP1468692B1 (en) * | 1993-12-10 | 2006-04-26 | Merrell Pharmaceuticals Inc. | Use of 2,6-di-alkyl-4-silyl-phenols for treating xanthoma |
US5677291A (en) * | 1993-12-10 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols |
AU2209097A (en) * | 1996-04-30 | 1997-11-19 | Hoechst Marion Roussel, Inc. | Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols |
US5608095A (en) * | 1996-04-30 | 1997-03-04 | Hoechst Marion Roussel, Inc. | Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents |
-
1998
- 1998-05-21 JP JP50442699A patent/JP2002506443A/ja active Pending
- 1998-05-21 AU AU75884/98A patent/AU7588498A/en not_active Abandoned
- 1998-05-21 EP EP98923645A patent/EP0996623A1/en not_active Withdrawn
- 1998-05-21 CA CA002295232A patent/CA2295232A1/en not_active Abandoned
- 1998-05-21 WO PCT/US1998/010443 patent/WO1998058937A1/en not_active Application Discontinuation
- 1998-06-18 ZA ZA985324A patent/ZA985324B/xx unknown
- 1998-06-22 AR ARP980102978A patent/AR013115A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
CA2295232A1 (en) | 1998-12-30 |
JP2002506443A (ja) | 2002-02-26 |
EP0996623A1 (en) | 2000-05-03 |
WO1998058937A1 (en) | 1998-12-30 |
ZA985324B (en) | 1999-01-07 |
AU7588498A (en) | 1999-01-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR023423A1 (es) | Derivados de adamantano, procedimientos para su preparacion, composicion farmaceutica, procedimiento para la preparacion de la composicion farmaceutica, yuso de dichos derivados para la manufactura de medicamentos | |
ES2161085T3 (es) | Formulaciones que contienen oxaliplatino. | |
PA8518801A1 (es) | Derivados de 2-aminocarbonil-9h-purina | |
PT998272E (pt) | Composicao farmaceutica para combinacao do descongestionante piperidinoalcanol | |
CO4930259A1 (es) | Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen | |
HN2001000224A (es) | Compuestos de imidazol condensado con arilo o heteroarilo como agentes anti - inflamatorios y analgesicos. | |
ES2144192T3 (es) | Nuevos derivados de 1-fenil-2-dimetil-amino-metil-ciclohexan-1-ol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ES2193337T3 (es) | Utilizacion de sales de estroncio para el tratamiento de la artrosis. | |
CU23393A3 (es) | Compuestos inhibidores de la raf kinasa y composiciones farmacéuticas que los contienen | |
GT200500007A (es) | [1,8]naftiridin-2-onas y compuestos relacionados para el tratamiento de la esquizofrenia. | |
AR027162A1 (es) | Compuestos de 2-fenil-3-fenoxilo-feniltio-benzotiofeno, sales farmaceuticamente aceptables de los mismos y composiciones farmaceuticas que los contienen | |
ES2126766T3 (es) | 7-azaindol-3-ilcarboxiamidas de tropilo como agente antitusivo. | |
PA8452701A1 (es) | Agonistas de prostaglandinas | |
AR021843A1 (es) | Derivados de propanolamina sustituidos con heterociclos, procedimiento para su preparacion, y su utilizacion. | |
SE9801494D0 (sv) | Novel use | |
ES2189072T3 (es) | Nuevo benzo-cicloalquenos heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
ATE253359T1 (de) | Antithrombotische mittel | |
BR9806083A (pt) | Composi-Æo farmac-utica para o tratamento da hapattite c | |
AR017664A1 (es) | Formulaciones farmaceuticas de liberacion sostenida que contienen inhibidores de la alfa-glucosidasa y su uso para la manufactura de un medicamento | |
ES2172023T3 (es) | Nuevos derivados tetrahidro-piridinicos sustituidos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
SV2002000112A (es) | Complejo farmaceutico ref.pcs10331aksr/bb | |
DE69813263T2 (de) | Hydrazono-benzazulen-derivate, pharmazeutische zusammensetzungen und zwischenprodukte | |
AR013115A1 (es) | COMPUESTOS DE 2,6-DI-t-BUTIL-4-[(DIMETIL-METOXIFENILSILIL)METIL-OXI]FENOL UTILES EN LA INHIBICION DE LA ARTERIOESCLEROSIS, COMPOSICIONES FARMACEUTICASY USOS EN LA FABRICACION DE MEDICAMENTOS QUE INCLUYEN DICHOS COMPUESTOS | |
ES2175661T3 (es) | Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
SV2002000418A (es) | Inhibidor del intercambiador de socio-hidrogeno de tipo 1 ref. pc1086aado/bb |